1. Home
  2. BRX vs IMVT Comparison

BRX vs IMVT Comparison

Compare BRX & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brixmor Property Group Inc.

BRX

Brixmor Property Group Inc.

HOLD

Current Price

$31.01

Market Cap

9.5B

Sector

Real Estate

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$38.60

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRX
IMVT
Founded
2011
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
8.0B
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
BRX
IMVT
Price
$31.01
$38.60
Analyst Decision
Buy
Buy
Analyst Count
12
8
Target Price
$31.58
$33.00
AVG Volume (30 Days)
2.4M
1.5M
Earning Date
04-27-2026
05-28-2026
Dividend Yield
4.12%
N/A
EPS Growth
12.61
N/A
EPS
0.41
N/A
Revenue
$1,371,597,000.00
N/A
Revenue This Year
$5.06
N/A
Revenue Next Year
$1.25
N/A
P/E Ratio
$76.10
N/A
Revenue Growth
6.73
N/A
52 Week Low
$24.66
$14.32
52 Week High
$32.80
$39.28

Technical Indicators

Market Signals
Indicator
BRX
IMVT
Relative Strength Index (RSI) 46.59 70.47
Support Level $30.79 $25.13
Resistance Level $31.49 N/A
Average True Range (ATR) 0.54 1.33
MACD -0.13 0.12
Stochastic Oscillator 12.57 94.08

Price Performance

Historical Comparison
BRX
IMVT

About BRX Brixmor Property Group Inc.

Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

Share on Social Networks: